Alaunos Therapeutics, Inc. Other Non-Current Liabilities
Alaunos Therapeutics, Inc. (TCRT) had Other Non-Current Liabilities of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-04-01
- 2023-12-31: Other Liabilities, Noncurrent $0.00.
- 2023-09-30: Other Liabilities, Noncurrent $0.00.
- 2023-06-30: Other Liabilities, Noncurrent $0.00.
- 2023-03-31: Other Liabilities, Noncurrent $28.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $28.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $28.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $28.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $28.00K 10-Q · filed 2022-08-15 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-07 | |
| 2015-06-30 | $17.00K 10-Q · filed 2015-08-10 | |
| 2014-09-30 | $20.00K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $20.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $20.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $20.00K 10-K · filed 2015-02-26 | |
| 2013-09-30 | $20.00K 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $2.58M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $2.17M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-03 | $12.96M 10-K · filed 2013-03-18 |
| 2012-09-30 | $21.53M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $25.47M 10-Q/A · filed 2012-08-28 | |
| 2012-03-31 | $25.19M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $19.43M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $22.58M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $36.01M 10-Q/A · filed 2011-08-09 | |
| 2010-12-31 | $27.31M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $21.09M 10-Q · filed 2011-08-01 | |
| 2009-12-31 | $18.47M 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |